Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Phinomics logo — Decoding Circular DNA to Revolutionize Precision Medicine

Phinomics

Decoding Circular DNA to Revolutionize Precision Medicine

Founded 2020 United States San Carlos, United States 7 employees Seed Biotechnology, Health Care +3

General Information

Company Name Phinomics
Founded Year 2020
Location United States San Carlos, United States
Employees 7
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Phinomics. To contact Phinomics, visit phinomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Phinomics compare?

A PDF of Phinomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Phinomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Phinomics

Phinomics is a biotechnology startup established in 2020 with the goal of revolutionizing diagnostics and identifying new therapies. The company specializes in developing genome-based technologies to detect disorders and identify disease-specific genetic markers. The innovative approach of Phinomics focuses on identifying single-cell patterns in circular DNA, known as the Circulome™, to diagnose, prevent, and treat disorders associated with topological and genetic changes in DNA. Based in the United States, Phinomics operates within the Biotechnology and Health Care industries. The startup recently received a Seed Round investment on 27 May 2022 from Springboard Health Angels. With the support of this investment, Phinomics aims to further advance its pioneering technologies and expand its capabilities in the field of genomic diagnostics and personalized medicine. The company's ambitious slogan, "Solving the Circular-DNA Puzzle," reflects its commitment to addressing critical medical challenges through cutting-edge genetic insights and technologies.

Business keywords: genome-based technologies, diagnostics, disease-specific genetic markers, circular DNA, single-cell patterns, Circulome, disorders, topological changes, genetic changes, DNA, genetic diagnostics, therapies, molecular diagnostics, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Springboard Health Angels
Springboard Health Angels
27 May 2022

Phinomics Alternatives & Competitors

View All Alternatives
Phinomics vs
Day Zero Diagnostics, Inc
Day Zero Diagnostics, Inc United States

The future of infectious disease diagnostics starts at Day Zero.

64 employees
Biotechnology, Health Care
Phinomics vs
Scripps Research Translational Institute
Scripps Research Translational Institute

Advancing genomics for groundbreaking diagnostics and personalized treatments

Grant
12 employees
Biotechnology, Health Care
Phinomics vs
CORE Diagnostics
CORE Diagnostics India

trusted . innovative . diagnostics

Venture round
459 employees
Biotechnology, Health Care
View all alternatives

FAQ About Phinomics

Decoding Circular DNA to Revolutionize Precision Medicine
Phinomics was founded in 2020.
Phinomics is headquartered in San Carlos, United States.
Phinomics operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Clean Energy. Its work centres on genome-based technologies, diagnostics, disease-specific genetic markers and circular DNA.
Phinomics has approximately 7 employees.
Phinomics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Phinomics include Day Zero Diagnostics, Inc, Scripps Research Translational Institute, CORE Diagnostics, OncoDNA, Mission Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phinomics and Day Zero Diagnostics, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phinomics, https://www.bouncewatch.com/company/phinomics, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout